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Potentially harmful, yet avoidable, interaction
between thiopentone and commonly used
muscle relaxants can endanger patients.
Case report
We report an interesting phenomenon we recently
encountered in our hospital. Our patient was a
healthy man who came in for an emergency
hernia repair due to suspected obstruction. Pre-
vious anaesthesia for an orthopaedic operation
the previous year had been uneventful. The plan
was to anaesthetize him with a rapid sequence
induction. This was done in view of the increased
risk of aspiration given that he was obstructed.
It was decided to use a modiﬁed rapid
sequence induction with rocuronium and thiopen-
tal sodium.
The induction was uneventful; pre-
oxygenation was followed by 375 mg of sodium
thiopental and 40 mg of rocuronium through a
20 G cannula connected to a 1000 mL Hartmann’s
solution. Upon intubation it was noted that the
patient was not fully relaxed despite an appropri-
ate dose of relaxant.
We then noticed that our previously free
running Hartmann’s infusion had stopped and
that there was a 10 cm long column of a ﬂuid con-
taining a ﬂaky precipitate in the IV line. Efforts to
ﬂush the line with 10 mL of saline through the
injection port were unsuccessful.
The patient was re-cannulated on the opposite
hand, and a dose of suxamethonium was given
to aid fast muscle relaxation with cricoid pressure
still in place. The patient was then intubated
without any harm. Surgery, subsequent extuba-
tion and recovery period were uneventful and
the patient was discharged home later that day.
The initial cannula was removed and examined
more closely to show that the lumen had indeed
occluded by the ﬂaky precipitate.
Following this clinical scenario we carried out
some simple experiments. We drew up a syringe
of commonly used muscle relaxants and pipetted
ﬁve 1 mL aliquots onto a ﬂat, sterile surface. To
each of these we then added 1 mL of sodium thio-
pental to see their interaction in vitro. The results
are shown in Figure 1.
Whereas the interaction with mivacurium pro-
duced practically no reaction, this did not appear
to be the case with the other relaxants we tested.
Suxamethonium produced a mild precipitate, fol-
lowed by atracurium. Vecuronium and rocuro-
nium, however, produced a rather marked
crystallization, producing macroscopically visible
precipitates. This may have been responsible for
our scenario where rocuronium given through a
poorly ﬂowing cannula may have led to crystalli-
zation of thiopental and subsequent occlusion of
the cannula/vessel.
To further test how dilution effected the crystal-
lization we added small amounts of Hartmann’s
solution to see if the precipitate would re-dissolve
(if at all).
Mixing with Hartmann’s solution brings about
some degree of dilution, however, no evident dis-
solving of the crystals. Rocuronium, in particular,
still produced a considerably ﬂaky precipitate.
Discussion
Although a rudimentary experiment, we believe it
highlights a potentially harmful interaction
between two very commonly used anaesthetic
drugs; one which we believe many anaesthetists
may well be unaware of. In particular, when
using rocuronium for rapid sequence, which we
feel is becoming more common practice, loss of
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CASE REPORT
1IV access when only half the required drug has
been administered can lead to unnecessary com-
plications and difﬁculty.
Literature search on the subject showed that a
few cases of precipitation of thiopental following
administration of certain muscle relaxants have
been reported.
1–3 The interaction seems to be a
resultofthedifferingpHofthetwodrugs(Table1).
There seems to be some correlation between the
relative difference in pH and the amount of crys-
tallization observed. Mivacurium, closest in pH
to thiopentone shows the least precipitation com-
pared with the other more acidic muscle relaxants.
The precipitate for the reaction has been shown by
UV spectrophotometry to be thiopentone acid,
4
and subsequent studies have shown that it is
highly insoluble in human plasma (<0.1 mg
mL
1), especially when compared with thiopental
(700 mg mLl
1).
3
Given the very common scenario in which
these drugs are used in combination, namely
induction and intubation, the importance of
avoiding complications at this crucial stage
cannot be overstated. Blocking off intravenous
access in an emergency situation is a dangerous
prospect. As well asthis injecting an insoluble pre-
cipitate into the circulation could, in our opinion,
have harmful sequelae.
We feel a combination of a free-ﬂowing drip as
well as ﬂuids running through it can minimize
potential difﬁculties. When no ﬂuids are being
administered, then a generous saline ﬂush may
well sufﬁce to clear cannula and vessel of thiopen-
tal, prior to administration of muscle relaxant.
Another potential solution is to alter the drugs
used. No reports were found with crystallization
and/or blockage of cannula/vessel when modi-
ﬁed rapid sequence was performed with propofol
and any of the muscle relaxant.
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Table 1
pH of thiopental and commonly used muscle
relaxants
Drug pH
Thiopentone 11–12
Suxamethonium 3.5
Mivacurium 4.0–5.0
Vecuronium 4.0
Atracurium 3.5
Rocuronium 4.0
Figure 1
Interaction between thiopental and a variety of
muscle relaxants (top row) and then with
addition of Hartmann’s solution (bottom row).
From left to right: Suxamethonium, Atracurium,
Mivacurium, Vecuronium, Rocuronium
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